Literature DB >> 21951385

Guidelines for the management of adult lower respiratory tract infections--full version.

M Woodhead1, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, T Schaberg, A Torres, G van der Heijden, R Read, T J M Verheij.   

Abstract

This document is an update of Guidelines published in 2005 and now includes scientific publications through to May 2010. It provides evidence-based recommendations for the most common management questions occurring in routine clinical practice in the management of adult patients with LRTI. Topics include management outside hospital, management inside hospital (including community-acquired pneumonia (CAP), acute exacerbations of COPD (AECOPD), acute exacerbations of bronchiectasis) and prevention. Background sections and graded evidence tables are also included. The target audience for the Guideline is thus all those whose routine practice includes the management of adult LRTI.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21951385      PMCID: PMC7128977          DOI: 10.1111/j.1469-0691.2011.03672.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  559 in total

1.  Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.

Authors:  Sheng-Hsiang Lin; Ping-Hung Kuo; Po-Ren Hsueh; Pan-Chyr Yang; Sow-Hsong Kuo
Journal:  Respirology       Date:  2007-01       Impact factor: 6.424

2.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

3.  Community-acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people.

Authors:  O Leroy; C Bosquet; C Vandenbussche; C Coffinier; H Georges; B Guery; S Alfandari; D Thevenin; G Beaucaire
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

4.  Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?

Authors:  Lance R Peterson
Journal:  Clin Infect Dis       Date:  2005-12-13       Impact factor: 9.079

Review 5.  Vaccines for preventing influenza in the elderly.

Authors:  Tom Jefferson; Carlo Di Pietrantonj; Lubna A Al-Ansary; Eliana Ferroni; Sarah Thorning; Roger E Thomas
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

6.  An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus.

Authors:  David M Patrick; Martin Petric; Danuta M Skowronski; Roland Guasparini; Timothy F Booth; Mel Krajden; Patrick McGeer; Nathalie Bastien; Larry Gustafson; Janet Dubord; Diane Macdonald; Samara T David; Leila F Srour; Robert Parker; Anton Andonov; Judith Isaac-Renton; Nadine Loewen; Gail McNabb; Alan McNabb; Swee-Han Goh; Scott Henwick; Caroline Astell; Jian Ping Guo; Michael Drebot; Raymond Tellier; Francis Plummer; Robert C Brunham
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-11       Impact factor: 2.471

7.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

8.  Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia.

Authors:  Heike von Baum; Santiago Ewig; Reinhard Marre; Norbert Suttorp; Susanne Gonschior; Tobias Welte; Christian Lück
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

9.  Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Authors:  Scott T Micek; Katherine E Kollef; Richard M Reichley; Nareg Roubinian; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

10.  Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak.

Authors:  Christine C Ginocchio; Frank Zhang; Ryhana Manji; Suman Arora; Mark Bornfreund; Leon Falk; Madhavi Lotlikar; Margaret Kowerska; George Becker; Diamanto Korologos; Marcella de Geronimo; James M Crawford
Journal:  J Clin Virol       Date:  2009-06-16       Impact factor: 3.168

View more
  265 in total

1.  [Antimicrobial treatment of patients with severe acute exacerbation of COPD].

Authors:  B Klapdor; S Ewig
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-22       Impact factor: 0.840

2.  First report of an outbreak of pneumonia caused by Streptococcus pneumoniae serotype 6A.

Authors:  Karla Prebil; Bojana Beović; Metka Paragi; Katja Seme; Tamara Kastrin; Blanka Kores Plesničar; Bojana Petek; Žiga Martinčič
Journal:  Wien Klin Wochenschr       Date:  2015-10-14       Impact factor: 1.704

3.  What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy.

Authors:  Simone Gattarello
Journal:  Curr Infect Dis Rep       Date:  2015-10       Impact factor: 3.725

4.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

5.  Procalcitonin for antibiotic treatment in intensive care unit patients.

Authors:  Nathalie Layios; Bernard Lambermont
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

6.  Should azithromycin no longer be considered a drug of choice for community-acquired pneumonia because of its potential to cause cardiovascular death?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2013-09

7.  Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Derek N Bremmer; Briana E DiSilvio; Crystal Hammer; Moeezullah Beg; Swati Vishwanathan; Daniel Speredelozzi; Matthew A Moffa; Kurt Hu; Rasha Abdulmassih; Jina T Makadia; Rikinder Sandhu; Mouhib Naddour; Noreen H Chan-Tompkins; Tamara L Trienski; Courtney Watson; Terrence J Obringer; Jim Kuzyck; Thomas L Walsh
Journal:  J Gen Intern Med       Date:  2018-02-05       Impact factor: 5.128

8.  Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.

Authors:  Ezgi Demirdogen Cetinoglu; Esra Uzaslan; Abdullah Sayıner; Aykut Cilli; Oguz Kılınc; Aysın Sakar Coskun; Armağan Hazar; Nurdan Kokturk; Ayten Filiz; Mehmet Polatli
Journal:  Hum Vaccin Immunother       Date:  2017-07-14       Impact factor: 3.452

9. 

Authors:  María José Monedero Mira; Manuel Batalla Sales; Concepción García Domingo; María José Monedero Mira; Belén Persiva Saura; Gloria Rabanaque Mallen; Lledó Tárrega Porcar
Journal:  FMC       Date:  2016-04-26

10.  Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia.

Authors:  Anna Maria Brambilla; Stefano Aliberti; Elena Prina; Francesco Nicoli; Manuela Del Forno; Stefano Nava; Giovanni Ferrari; Francesco Corradi; Paolo Pelosi; Angelo Bignamini; Paolo Tarsia; Roberto Cosentini
Journal:  Intensive Care Med       Date:  2014-05-10       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.